Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K

5 Oct 2009

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to PI3K/AKT/mTOR signaling in cancer
Share to Protein Kinase Regulation and GTPase Signaling
Share to Renal Diseases and Glomerulopathies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 19802009
DOI: 10.1038/onc.2009.315

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17KPMID 19802009Read ↗

Effect of AKT1 (p. E17K) Hotspot Mutation on Malignant Tumorigenesis and PrognosisSemantic proximity Read ↗

AKT1 E17 K pleckstrin homology domain mutation in urothelial carcinoma.Semantic proximity Read ↗

An activating mutation in AKT1 in human prostate cancer.Semantic proximity Read ↗

AKT1 and PIK3CA activating mutations in Moroccan bladder cancer patients´ biopsies and matched urine.Semantic proximity Read ↗

E17K substitution in AKT1 in prostate cancerSemantic proximity Read ↗

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer.Semantic proximity Read ↗

A new mutational AKTivation in the PI3K pathway.Semantic proximity Read ↗

Bladder cancer: mutation found in >70% of tumours.Semantic proximity Read ↗

TSC1 involvement in bladder cancer: diverse effects and therapeutic implicationsSemantic proximity Read ↗

Experimental analysis of bladder cancer-associated mutations in EP300 identifies EP300-R1627W as a driver mutation.Semantic proximity Read ↗

Recurrent AKT mutations in human cancers: functional consequences and effects on drug sensitivity.Semantic proximity Read ↗

AKT1(E17K) in human solid tumours.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.